UK markets open in 2 hours 34 minutes

Vifor Pharma AG (GNHAY)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
28.430.00 (0.00%)
At close: 9:33AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 58.53B
Enterprise value 37.91B
Trailing P/E 40.19
Forward P/E 119.96
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)4.97
Price/book (mrq)2.53
Enterprise value/revenue 34.60
Enterprise value/EBITDA 713.29

Trading information

Stock price history

Beta (5Y monthly) 1.32
52-week change 3-10.20%
S&P500 52-week change 331.29%
52-week high 332.10
52-week low 325.81
50-day moving average 327.93
200-day moving average 328.21

Share statistics

Avg vol (3-month) 340
Avg vol (10-day) 312
Shares outstanding 5324.28M
Implied shares outstanding 6N/A
Float 8234.23M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.44
Forward annual dividend yield 41.55%
Trailing annual dividend rate 32.00
Trailing annual dividend yield 37.03%
5-year average dividend yield 4N/A
Payout ratio 460.71%
Dividend date 326 May 2021
Ex-dividend date 409 May 2021
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CHF.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021


Profit margin 23.74%
Operating margin (ttm)21.51%

Management effectiveness

Return on assets (ttm)4.80%
Return on equity (ttm)8.91%

Income statement

Revenue (ttm)1.75B
Revenue per share (ttm)5.40
Quarterly revenue growth (yoy)-1.00%
Gross profit (ttm)1.06B
Net income avi to common (ttm)213.3M
Diluted EPS (ttm)1.39
Quarterly earnings growth (yoy)83.20%

Balance sheet

Total cash (mrq)626.2M
Total cash per share (mrq)1.93
Total debt (mrq)605.9M
Total debt/equity (mrq)16.10
Current ratio (mrq)2.96
Book value per share (mrq)10.41

Cash flow statement

Operating cash flow (ttm)441M
Levered free cash flow (ttm)146.79M